UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A review of malaria vaccine clinical projects based on the WHO rainbow table

Malaria journal, 2012-01, Vol.11 (1), p.11-11, Article 11

2012

Volltextzugriff (PDF)

Experimental human challenge infections can accelerate clinical malaria vaccine development

Nature reviews. Immunology, 2011-01, Vol.11 (1), p.57-64

2011

Volltextzugriff (PDF)

Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results

PLoS medicine, 2015-04, Vol.12 (4), p.e1001819-e1001819

2015

Volltextzugriff (PDF)

Developing Global Norms for Sharing Data and Results during Public Health Emergencies

PLoS medicine, 2016-01, Vol.13 (1), p.e1001935-e1001935

2016

Volltextzugriff (PDF)

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

Malaria journal, 2009-12, Vol.8 (1), p.312-312, Article 312

2009

Volltextzugriff (PDF)

Design, recruitment, and microbiological considerations in human challenge studies

The Lancet infectious diseases, 2015-07, Vol.15 (7), p.840-851

2015

Volltextzugriff (PDF)

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

Vaccine, 2016-06, Vol.34 (26), p.2865-2869

2016

Volltextzugriff (PDF)

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Vaccine, 2013-04, Vol.31, p.B233-B243

2013

Volltextzugriff (PDF)

Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015

Emerging infectious diseases, 2016-08, Vol.22 (8)

2016

Volltextzugriff (PDF)

Decision-making on malaria vaccine introduction: the role of cost―effectiveness analyses

Bulletin of the World Health Organization, 2012-11, Vol.90 (11), p.864-866

2012

Volltextzugriff (PDF)

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

Vaccine, 2016-01, Vol.34 (2), p.190-197

2016

Volltextzugriff (PDF)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection

PloS one, 2013-04, Vol.8 (4), p.e61395-e61395

2013

Volltextzugriff (PDF)

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

PLoS medicine, 2004-11, Vol.1 (2), p.e33-e33

2004

Volltextzugriff (PDF)

Reducing empiricism in malaria vaccine design

The Lancet infectious diseases, 2010-03, Vol.10 (3), p.204-211

2010

Volltextzugriff (PDF)

Malaria vaccine technology roadmap

The Lancet (British edition), 2013-11, Vol.382 (9906), p.1700-1701

2013

Volltextzugriff (PDF)

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7355-7362

2019

Volltextzugriff (PDF)

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7307-7314

2019

Volltextzugriff (PDF)

MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

Malaria journal, 2012-11, Vol.11 (1), p.372-372, Article 372

2012

Volltextzugriff (PDF)

How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database

PloS one, 2014-07, Vol.9 (7), p.e101826-e101826

2014

Volltextzugriff (PDF)

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps

Vaccine, 2016-06, Vol.34 (26), p.2939-2947

2016

Volltextzugriff (PDF)

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation

Nature medicine, 2016-07, Vol.22 (7), p.701-705

2016

Volltextzugriff (PDF)

Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men

The Journal of infectious diseases, 2004-06, Vol.189 (12), p.2213-2219

2004

Volltextzugriff (PDF)

Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei

PloS one, 2010-08, Vol.5 (8), p.e12294-e12294

2010

Volltextzugriff (PDF)

A randomised controlled trial of two infusion rates to decrease reactions to antivenom

PloS one, 2012-06, Vol.7 (6), p.e38739

2012

Volltextzugriff (PDF)

Comparison of clinical and parasitological data from controlled human malaria infection trials

PloS one, 2012-06, Vol.7 (6), p.e38434-e38434

2012

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(126)
Dissertationen
(1)

Sprache

Englisch
(126)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A review of malaria vaccine clinical projects based on the WHO rainbow table

Experimental human challenge infections can accelerate clinical malaria vaccine development

Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results

Developing Global Norms for Sharing Data and Results during Public Health Emergencies

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

Design, recruitment, and microbiological considerations in human challenge studies

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015

Decision-making on malaria vaccine introduction: the role of cost―effectiveness analyses

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

Reducing empiricism in malaria vaccine design

Malaria vaccine technology roadmap

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016

MALVAC 2012 scientific forum: accelerating development of second-generation malaria vaccines

How frequently do the results from completed US clinical trials enter the public domain?--A statistical analysis of the ClinicalTrials.gov database

The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation

Phase 1 Evaluation of 3 Highly Immunogenic Prime-Boost Regimens, Including a 12-Month Reboosting Vaccination, for Malaria Vaccination in Gambian Men

Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei

A randomised controlled trial of two infusion rates to decrease reactions to antivenom

Comparison of clinical and parasitological data from controlled human malaria infection trials

Suchergebnisse filtern